5
New Heaven Chemicals & Industries
524484 BSE
New Heaven Chemicals & Industries
Healthcare BSE: 524484 Pharmaceuticals & Biotechnology
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
1- Company has low interest coverage ratio.
Growth Rate
Net Income Growth
-50% lower than
3Y
Quarterly Results
| Particulars | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.2 | 0.04 | 0.02 | 0.01 | 0.11 | 0.04 | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 | 0.01 | 0.12 |
| Operating Profit | -0.2 | -0.04 | -0.02 | -0.01 | -0.11 | -0.04 | -0.01 | -0.01 | -0.04 | -0.01 | -0.01 | -0.01 | -0.12 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | -0.24 | -0.07 | -0.05 | -0.04 | -0.14 | -0.05 | -0.01 | -0.01 | -0.04 | -0.01 | -0.01 | -0.01 | -0.12 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.25 | -0.07 | -0.05 | -0.04 | -0.14 | -0.04 | -0.01 | -0.01 | -0.04 | -0.01 | -0.01 | -0.01 | -0.12 |
| EPS in Rs | -0.48 | -0.14 | -0.1 | -0.08 | -0.27 | -0.08 | -0.02 | -0.02 | -0.08 | -0.02 | -0.02 | -0.02 | -0.23 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.12 | 3.03 | 0.05 | 0.05 | 0.08 | 0.41 | 0.17 | 0.2 | 0.11 | 0.08 | 0.15 |
| Operating Profit | -0.12 | -3.03 | -0.05 | -0.05 | -0.08 | -0.41 | -0.17 | -0.2 | -0.11 | -0.08 | -0.15 |
| Other Income | 0 | 5.81 | 0 | 0 | 0 | 0 | 0 | -1.48 | 0 | 0 | 0 |
| Interest | 2.63 | 3.34 | 2.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.03 | 0.02 | 0 |
| PBT | -2.75 | -0.56 | -2.82 | -0.05 | -0.08 | -0.41 | -0.17 | -1.72 | -0.14 | -0.1 | -0.15 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | -2.75 | -0.56 | -2.82 | -0.05 | -0.08 | -0.41 | -0.17 | -1.73 | -0.14 | -0.1 | -0.15 |
| EPS in Rs | -5.33 | -1.09 | -5.47 | -0.1 | -0.16 | -0.79 | -0.33 | -3.35 | -0.27 | -0.19 | -0.29 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.09 | 5.09 | 5.09 | 5.09 | 5.16 | 5.16 | 5.16 | 5.16 | 5.16 | 5.16 |
| Reserves | -18.39 | -18.95 | -24.39 | -24.43 | -20.72 | -21.12 | -21.29 | -23.51 | -10.74 | -10.85 |
| Borrowings | 19.07 | 19.53 | 24.96 | 25 | 21.28 | 21.29 | 21.46 | 21.62 | 8.81 | 8.89 |
| Other Liabilities | 0.72 | 0.72 | 0.72 | 0.72 | 0.73 | 0.01 | 0.01 | 0.03 | 0.03 | 0.05 |
| Total Liabilities | 6.49 | 6.39 | 6.38 | 6.38 | 6.45 | 5.34 | 5.34 | 3.3 | 3.26 | 3.25 |
| Fixed Assets | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 1.32 | 0.32 | 0.28 | 0.26 |
| CWIP | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | 0.01 | 0.01 | 0.01 |
| Investments | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 | 2.95 |
| Other Assets | 1.89 | 1.79 | 1.78 | 1.78 | 1.85 | 0.74 | 0.74 | 0.02 | 0.02 | 0.03 |
| Total Assets | 6.49 | 6.39 | 6.38 | 6.38 | 6.45 | 5.34 | 5.34 | 3.3 | 3.26 | 3.25 |
Cash Flow
| Particulars | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -0.07 | -0.5 | -0.06 | -0.05 | -0.09 | -0.05 | -0.17 | -0.16 | -0.1 | -0.08 |
| Investing | 0 | 0 | 0 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 |
| Financing | 0.07 | 0.5 | 0.06 | 0.05 | 0 | 0.01 | 0.16 | 0.16 | 0.1 | 0.08 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0.06 | -0.04 | -0.01 | -0.01 | 0 | 0 |
| Free Cash Flow | -0.07 | -0.5 | -0.06 | -0.05 | -0.09 | -0.05 | -0.17 | -0.16 | -0.1 | -0.08 |
| CFO/OP | 58 | 16 | 120 | 100 | 112 | 12 | 100 | 80 | 91 | 100 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | -2.1% | — | -0.88% | -1.41% | -7.42% | -3.19% | -5.58% | -4.31% | -3.11% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view New Heaven Chemicals & Industries insights
44 extracted metrics + investor summaries across FY06–FY22.
Documents
2
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
14 Oct 2025 - Scheme effective Oct 14, 2025; Record Date Oct 28; Yaari shares issued 294/100 (fully), 162/100 (partly paid 55%). 14 Oct 2025 - Scheme effective Oct 14, 2025; Record Date Oct 28; Yaari shares issued 294/100 (fully), 162/100 (partly paid 55%).
3
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Oct 2025 - Certificates confirming dematerialization/rematerialization details furnished for quarter ended Sept 30, 2025. 10 Oct 2025 - Certificates confirming dematerialization/rematerialization details furnished for quarter ended Sept 30, 2025.
4
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') - ESG Rating
10 Oct 2025 - CRISIL ESG assigned "Crisil ESG 52" to Dhani; unsolicited rating based on public data (Oct 10, 2025). 10 Oct 2025 - CRISIL ESG assigned "Crisil ESG 52" to Dhani; unsolicited rating based on public data (Oct 10, 2025).
5
Compliance Status Of Regulation 6 (1) And 7(1) Of SEBI (LODR) Regulations, 2015, As Amended, For The Quarter Ended September 30, 2025
6 Oct 2025 - Confirms compliance with SEBI Regulations 6(1) and 7(1) for quarter ended September 30, 2025. 6 Oct 2025 - Confirms compliance with SEBI Regulations 6(1) and 7(1) for quarter ended September 30, 2025.
Frequently Asked Questions about New Heaven Chemicals & Industries
What does New Heaven Chemicals & Industries Ltd do?
Trans Medicare Limited is engaged in the manufacturing of pharmaceutical products.
Where is New Heaven Chemicals & Industries Ltd (524484) listed?
New Heaven Chemicals & Industries Ltd trades under code 524484 on the BSE.
Which sector does New Heaven Chemicals & Industries Ltd belong to?
New Heaven Chemicals & Industries Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
Company Information
Trans Medicare Limited is engaged in the manufacturing of pharmaceutical products.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524484.md for New Heaven Chemicals & Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.